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Integrin-mediated cell adhesion and spreading enables cells to respond to extracellular stimuli for cellular
functions. Using a gastric carcinoma cell line that is usually round in adhesion, we explored the mechanisms
underlying the cell spreading process, separate from adhesion, and the biological consequences of the process.
The cells exhibited spreading behavior through the collaboration of integrin-extracellular matrix interaction
with a Smad-mediated transforming growth factor 1 (TGF1) pathway that is mediated by protein kinase C
(PKC). TGF1 treatment of the cells replated on extracellular matrix caused the expression and phosphor-
ylation of PKC, which is required for expression and activation of integrins. Increased expression of integrins
2 and 3 correlated with the spreading, functioning in activation of focal adhesion molecules. Smad3, but not
Smad2, overexpression enhanced the TGF1 effects. Furthermore, TGF1 treatment and PKC activity were
required for increased motility on fibronectin and invasion through matrigel, indicating their correlation with
the spreading behavior. Altogether, this study clearly evidenced that the signaling network, involving the
Smad-dependent TGF pathway, PKC expression and phosphorylation, and integrin expression and activa-
tion, regulates cell spreading, motility, and invasion of the SNU16mAd gastric carcinoma cell variant.
Integrin-mediated adhesion to extracellular matrix (ECM)
proteins allows cells to efficiently respond to extracellular stim-
uli for spreading, proliferation, migration, invasion, and gene
transcription. This response is mediated by bidirectional signal
transduction between extracellular and intracellular spaces
that cross talks with other signal pathways (2, 3, 15, 22). Inte-
grins, a family of cell adhesion receptors, are composed of an
 and a  subunit. They transduce direct signaling via engage-
ments with ECM proteins, leading to the regulation of down-
stream intracellular signaling molecules. They also function in
collaborative (indirect) signaling, in which integrins cosignal
with other membrane receptor-mediated signal pathways (e.g.,
growth factor receptors, G-protein coupled receptors, or the
transforming growth factor 1 [TGF1] signaling pathway) (4,
8, 17, 25, 38, 43).
TGF1 is a multifunctional cytokine which inhibits cell
growth and also mediates cell differentiation and metastasis.
Activation of TGF1 receptor complex by TGF1 binding
propagates intracellular signal transduction, involving Smad
proteins, to regulate numerous developmental and homeo-
static processes via regulations in gene induction (1). Smad7 is
a major inhibitory Smad, which inhibits the TGF1-mediated
phosphorylation of R-Smad2 and R-Smad3 through competi-
tion with Smad2/3 for binding to the TGF1 receptor (29).
Recently, TGF1 was demonstrated to activate a variety of
intracellular signaling molecules, including mitogen-activated
protein kinases (MAPKs) (9, 12, 45) and small GTPases (28),
either by Smad-dependent or -independent signaling pathways
(7). TGF1 signaling modulates the expression of ECM pro-
teins (14, 34) and integrins (27). Conversely, integrin-mediated
signaling also regulates TGF1 expression levels (16, 21). Al-
though this collaborative relationship between integrin- and
TGF1-mediated signal pathways appears to be important for
diverse cellular functions, mechanistic details underlying their
collaboration and signaling network are largely unknown.
Protein kinase C (PKC) is a member of a novel family of
the PKC families and can be activated by either diacylglycerol
or phorbol ester (44). PKC has been shown to exert antitu-
morigenic or tumorigenic effects, depending on the nature of
cellular stimuli (37). Although PKC has been implicated in
ECM synthesis, as shown in a couple of previous studies (13,
46), the evidence is not conclusive for its roles in TGF1-
mediated regulation of cell functions.
So far, signaling networks consisting of integrins, TGF1,
and PKC (especially PKC) have not been thoroughly investi-
gated, especially for cell spreading and invasiveness. In this
study, we have attempted to mechanistically explore the sig-
naling networks which regulate the cell spreading process, sep-
arately from the adhesion process. A gastric carcinoma cell line
that is usually round in adhesion was used, so that stimuli-
induced spreading was investigated with regards to signal cross
talks between TGF1, integrin, and PKC. We observed the
signaling network in which Smad-dependent TGF1 signaling
to integrin-mediated signaling is mediated by expression and
activation of PKC, leading to cell spreading. Furthermore, we
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also investigated the biological consequences inherent in the
signal network-mediated cell spreading.
MATERIALS AND METHODS
Cells. SNU16mAd cells, a variant cell line enriched with adherent cells, were
obtained from subsequent cultures by collecting adherent cells among mostly
anchorage-independent SNU165 cells (18). SNU16mAd cells were cultured at
37°C and 5% CO2, in RPMI 1640 culture media containing 10% (vol/vol) fetal
bovine serum and 0.2 mg/ml G418.
Cell lysate preparation and Western blots. Replating of SNU16mAd cells on
diverse ECM-precoated dishes (10 g/ml fibronectin [Fn], 10 g/ml collagen
type I, 10 g/ml vitronectin, 10 g/ml laminin I [Chemicon, Temecula, CA], or
10 g/ml poly-L-lysine [PL; Sigma]) was done as explained previously (25). In
certain cases, pharmacological inhibitors (12.5 M GF-109203X or 10 M rot-
tlerin [10] [Calbiochem, San Diego, CA]) were pretreated, 30 min prior to the
replating without or with TGF1 treatment. Upon replating, TGF1 (5 ng/ml;
Chemicon) was added directly to the replating media, and the treatment lasted
for 20 h or indicated periods. In cases of experiments with protein synthesis
inhibition, 12 h after the replating, certain cells were treated with 10 g/ml
cycloheximide (Sigma), a protein synthesis inhibitor, with or without a concom-
itant 5 ng/ml TGF1, followed by additional incubation for 8 h (retreated every
4 h) for a total of 20 h of incubation on Fn. In certain cases, cells were premixed
with 10 g/ml anti-integrin 2 (P1E6), 3 (P1B5), or 5 (P1D6) antibodies
(Chemicon), 30 min before the replating on Fn and a concomitant TGF1
treatment for 20 h. In cases in which adenovirus for either LacZ, FLAG-tagged
Smad2, Smad3, Smad7 (25), PKC, or dominant-negative PKC (K368R mu-
tant) (kind gifts from J.-S. Chun, Gwangju Institute of Science and Technology,
Gwangju, Korea) was separately infected, 24 h after the infection, cells were
replated on ECM without or with TGF1 treatment for 20 h. In cases in which
the TGF1 treatment periods were shorter (see Fig. 3A, 4C, and 6C), the
indicated periods (x h) from the end of a total of 20 h of incubation were with
TGF1, after certain incubations (20  x h) without TGF1. In the case of PKC
knockout via introduction of small interfering RNA (siRNA) (QIAGEN),
siRNA against either PKC (to target AAG ATG AAG GAG GCG CTC AG;
QIAGEN, catalog no. 1022453) or its negative control (AAT TCT CCG AAC
GTG TCA CGT; QIAGEN, catalog no. 1022079) was separately transfected
using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA), according to the
manufacturer’s protocols. The target sequence of PKC siRNA was unique for
PKC according to NCBI BLAST searches. In cases of integrin  subunit over-
expression, pSF2-human integrin 2, 3, or pcDM5 (23) or pEF-PKC was
separately transfected as above. Twenty-four hours after the transfection, cells
were replated on either Fn-precoated dishes or cover glasses in the absence or
presence of TGF1 treatment for 20 h. Cell lysates were prepared as described
in the previous studies (24, 25). The lysates were used in Western blots using
phospho-Y397FAK, phospho-Y925FAK, phospho-Y416Src, PKC, PKC, c-Src
(Santa Cruz Biotechnology, Santa Cruz, CA), phospho-Y118paxillin, phospho-
PKCs (Cell Signaling Technology, Beverly, MA), FLAG (Sigma), integrins 2,
3, or 4, human laminin 5 (P3H9-2 clone) (Chemicon), focal adhesion kinase
(FAK), paxillin, p130Cas, Nck, -tubulin, 5 (BD Transduction Laboratories,
San Jose, CA), or type I collagen (Biodesign, Saco, ME). In some cases, the
membrane was stripped by incubation in a stripping buffer (62.5 mM Tris, pH
6.8, 2% sodium dodecyl sulfate [SDS], and 100 mM -mercaptoethanol) at 65°C
for 30 min, washed for 1 h (3 times for 20 min) with Tris-based saline with 0.05%
Tween-20 (TBST), reblocked with TBST containing 1% bovine serum albumin
(BSA) plus 1% skim milk proteins, and then reprobed with another primary
antibody.
Immunofluorescence microscopy. Cells were first cotransfected with pcDNA3-
GFP with either FAK-related nonkinase (FRNK, pBS-FRNK; a kind gift from
Juliano L. Rudy, University of North Carolina, Chapel Hill, NC), pKH3-Y416F
c-Src (18a), or pCMV-Y31/118/157F paxillin (31). Twenty-four hours later, cells
were replated on 10 g/ml Fn-precoated glass coverslips and incubated for 20 h
at 37°C. After incubation, cells were fixed with 3.7% formaldehyde in phosphate-
buffered saline (PBS), permeabilized with 0.5% Triton X-100 in PBS at room
temperature, and washed three times with PBS. The cells were then incubated
with anti-phospho-Y397FAK antibody for 1 h and washed three times with PBS
(3 times for 10 min). Cells were then incubated with anti-rabbit immunoglobulin
G (IgG)-conjugated TRITC (Chemicon) in a dark and humidified chamber for
1 h. In the case of actin staining, cells were cotransfected with pSF2-integrin 2,
3, or pcDM5 (23), control siRNA (see above), or PKC siRNA and pcDNA3-
GFP constructs, replated on Fn, fixed, and permeabilized as explained above.
Cells were then stained with phalloidin-conjugated TRITC (Molecular Probes,
Eugene, OR) for 1 h before washing three times with PBS and mounting with a
mounting solution (DakoCytomation, Germany). Mounted samples were visu-
alized by a fluorescent microscope.
Immunoprecipitation. Cells were replated on Fn under diverse conditions as
explained above. After the 20-h incubation, cells were washed with cold PBS and
immediately lysed in an immunoprecipitation buffer (10 mM Tris-HCl, pH 7.4,
150 mM NaCl, 0.5 mM EGTA, 0.2 mM Na3VO4, 0.2 mM phenylmethylsulfonyl
fluoride, 1% Triton X-100, and 0.5% NP-40) on ice. The lysates were cleared by
a centrifugation at 13,000 rpm for 30 min at 4°C. An equal amount of anti-FAK
or Nck antibody was added directly to the cell extracts with an equal amount of
proteins and incubated for 2 h or overnight at 4°C with rotation. After incuba-
tion, 30 l of 50% slurry of protein A/G Sepharose beads (Upstate, Waltham,
MA) was added to each sample, and incubation for an additional 2 h at 4°C with
rotation was done. Immunoprecipitates were collected by a centrifugation at
13,000 rpm for 3 min at 4°C and washed twice with ice-cold lysis buffer and twice
with cold PBS. The immunoprecipitates were then eluted with 2 SDS-poly-
acrylamide gel electrophoresis (PAGE) sample buffer, and proteins were sepa-
rated by SDS-PAGE and probed via standard Western blotting.
Flow cytometry. Flow cytometric measurements of integrin subtypes on cells
were performed as described previously (23). To study the TGF1 effects on
integrin expression levels in a time-dependent manner, one set of cells was
replated on Fn and concomitantly untreated or treated with 5 ng/ml TGF1 for
0, 8, 12, or 20 h at the end of a total of 20 h incubation, before harvesting for the
measurements. To study the effects of PKC inhibition on integrin expression,
cells were replated on Fn in the absence or presence of 5 ng/ml TGF1 treatment
without or with pretreatment of 12.5 M GF-109203X. The raw data were
analyzed by using a software program (WinMDI 2.7; Scripps Institute, San
Diego, CA).
Wound-healing assay. Normal cells or PKC wild type (WT)-expressing ade-
novirus (Ad-PKC)-infected cells in the serum-free replating media were seeded
at a high density on 60-mm culture dishes precoated with Fn (10 g/ml). Twelve
hours later, wounds were made by scraping through the cell monolayer with a
pipette tip. Cells were washed twice with RPMI 1640 and then treated with 5
ng/ml TGF1 in the absence or presence of PKC inhibitors (GF-109203X or
rottlerin). After 36 h of incubation at 37°C, several images around wounds in
each condition were taken.
Invasion assay. A thick layer of matrigel (90 l of 2.84 mg/ml per well of a
24-well transwell chamber) (BD Biosciences, Oxford, United Kingdom) was
prepared on an upper chamber 6 h prior to cell replating. Routinely, the thick-
ness of the layer was 500 mm. Normal or Ad-PKC WT-infected cells in serum-
free RPMI containing 1% BSA were then replated on top of the matrigel. The
lower chamber was filled with RPMI 1640 containing 10% fetal bovine serum or
1% BSA. After incubation for 72 h, cells inside of the upper chamber were
mopped up. Cells beneath the membrane filter were fixed with 3.7% formalde-
hyde in PBS and stained with crystal violet, and images were taken with a
phase-contrast microscope.
Statistical analysis. Paired Student’s t tests were performed for comparisons
of mean values to see if the difference is significant. P values of 0.05 were
considered significant.
RESULTS
TGF1-, integrin-, and PKC-mediated spreading of gastric
carcinoma cells. We have interests in studying the roles of
collaborative signaling of integrins with the TGF1 pathway in
regulation of cellular behaviors. Specifically, we observed that
TGF1 treatment of normally round-shape SNU16mAd gas-
tric carcinoma cells on Fn caused spreading (Fig. 1A). In order
to determine if this TGF1-mediated cell spreading requires
integrin-mediated engagements with ECMs, cells were re-
plated on PL with a concomitant 5 ng/ml TGF1 treatment for
20 h. However, TGF1 treatment did not cause spreading in
cells replated on PL (Fig. 1A). Furthermore, TGF1-induced
cell spreading appeared to depend on Smad pathways, since
cells infected with adenovirus encoding for the Smad7, an
inhibitory Smad, blocked the spreading, whereas cells infected
with adenovirus for -galactosidase (Ad-LacZ) maintained
spread (Fig. 1B). These data suggest that both integrin engage-
ment to ECM and Smad-dependent TGF1 signaling are re-
quired for spreading of the gastric carcinoma cells.
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We next examined the effects of various pharmacological
inhibitor treatments to determine which intracellular signaling
molecules were responsible for the integrin- and TGF1-me-
diated spreading. In these tests, we found that the cell spread-
ing was blocked by PKC inhibition using GF-109203X (a gen-
eral inhibitor of PKCs) or rottlerin (Rot, an inhibitor of PKC)
(Fig. 2A). These results indicate that SNU16mAd cell spread-
ing depends on integrin, TGF1, and PKC signal transduction.
To determine which PKC isoform(s) is involved in the cell
spreading, we attempted to correlate phosphorylation of the
isoforms with the spreading behaviors. Among the isoforms,
Ser643 phosphorylation of PKC correlated closely with the
spreading behaviors; cell spreading and Ser643 phosphoryla-
tion of PKC were minimal in the absence of TGF1 treat-
ment on Fn but were induced by TGF1 in a GF treatment-
dependent manner (Fig. 2B). However, PKC/II, PKCε,
PKC	/
, and PKC appeared not to be involved in the spread-
ing, since phosphorylation of PKC/II at Thr638/641 did not
correlate with the spreading behaviors (Fig. 2B) and PKCε
phosphorylation by using anti-phospho-pan PKC antibody and
PKC	/
 at Thr410/403 did not either (data not shown). PKC
was not expressed in the cells (data not shown). Taken to-
gether, these observations suggest that integrin- and TGF1-
mediated SNU16mAd cell spreading may involve PKC.
The cell spreading requires activation of focal adhesion
molecules. Because integrin-mediated cell adhesion and
spreading activates focal adhesion (FA) molecules including
FAK, paxillin, and c-Src, we analyzed phosphorylation of these
molecules when TGF1 was used to treat cells on Fn for
various periods (Fig. 3A). It was observed that the longer
TGF1 was treated at the end of the total 20-h incubation, the
higher the phosphorylations of FAK Tyr397, paxillin Tyr118,
c-Src Tyr416, and PKC Ser643 (Fig. 3A). Interestingly, in
addition to Ser643 phosphorylation, TGF1 treatment for
longer than 4 h at the end of the 20-h incubation (e.g., 8 h) also
enhanced PKC expression (Fig. 3A). In addition, blocking of
FIG. 1. Integrin- and TGF1-mediated spreading of gastric carcinoma cells on fibronectin. (A) TGF1 and integrin signaling are required for
spreading of gastric SNU16mAd carcinoma cells on fibronectin. The cells were trypsinized, collected, washed with RPMI 1640 containing 1% BSA,
kept in suspension for 1 h at 37°C with rolling over, replated on Fn (10 g/ml)- or PL (10 g/ml)-precoated dishes, and incubated without or with
5 ng/ml TGF1 treatment for 20 h. Phase-contrast images were taken after the incubation. (B) Integrin- and TGF1-mediated cell spreading was
blocked by Smad7 overexpression. Cells were infected with adenovirus encoding for -galactosidase (LacZ) or Smad7, an inhibitory Smad.
Twenty-four hours later, infected cells were manipulated, as explained above.
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PKC activity by pharmacological inhibitors (GF-109203X or
rottlerin) decreased phosphorylation of the FA molecules (Fig.
3B). These data demonstrated that TGF1-, integrin-, and
PKC-mediated cell spreading correlated with phosphorylation
of the FA molecules. In order to verify the correlation of cell
spreading with phosphorylation of the FA molecules, we ex-
amined the spreading of cells transiently cotransfected with the
expression vectors of green fluorescent protein (GFP) and
either dominant-negative or inactive forms of the FA mole-
cules. Transfection of GFP alone did not block the TGF1-
mediated spreading (see Fig. 6E). Cells transfected with
FRNK (dominant negative), dominant-negative (Y31/118/
157F) paxillin, or inactive (Y416F) c-Src did not spread by
TGF1 treatment on Fn, whereas the surrounding untrans-
fected cells did (Fig. 3C). Among GFP-positive cells, 90% (
3.0%) of FRNK-transfected cells, 85% ( 4.5%) of Y31/118/
157F paxillin-transfected cells, and 92% ( 3.2%) of Y416F
c-Src-transfected cells showed round shapes [i.e., (the longest
distance from one end to the other end of a cell)/(the shortest
distance)  2.0]. Previously it was shown that a complex for-
mation of FAK with other adapter proteins including p130Cas
was involved in cell spreading (5). In this study, formation of a
protein complex including FAK, p130Cas, and Nck correlated
with the cell spreading behaviors (Fig. 3D), supporting a pre-
vious suggestion that the complex might stabilize the active
multiprotein complex at FAs (6). Therefore, these data suggest
that the TGF1-, integrin-, and PKC-mediated cell spreading
requires activation of the FA molecules and also involves for-
mation of stable protein complexes at FAs.
The cell spreading requires new synthesis of PKC and
integrins 2 and 3. To determine whether the cell spreading
depends on new protein synthesis, we examined the effects of
cycloheximide treatment on the cell spreading. Inhibition of
protein synthesis abolished phosphorylation of the FA mole-
cules, expression and Ser643 phosphorylation of PKC (Fig.
4A, left), and cell spreading (Fig. 4A, right) by TGF1 treat-
ment. In addition to increased expression of PKC by TGF1
(Fig. 3A and 4A), the cell spreading also correlated with in-
creased expression of integrins 2 and 3, but not integrins 4
or 5, 1-conjugating integrins, 1(I) or 2(I) collagen I
chains (a major integrin 2 binding partner), or 3 chain of
laminin 5 (a major integrin 3 binding partner), in a cyclohex-
imide treatment-dependent manner (Fig. 4B and data not
shown). Flow cytometric analysis also revealed that TGF1
treatments with cells on Fn increased the expression of inte-
grins 2 and 3 on the cell surface in a time-dependent man-
ner (Fig. 4C); the expression was inhibited by PKC inhibition
(Fig. 4D) or Smad7 overexpression (Fig. 4E). Taken together,
these data suggest that the cell spreading mediated by TGF1,
integrin, and PKC pathways involves Smad-dependent in-
creases in PKC expression and Ser643 phosphorylation and
expression of integrins 2 and 3.
Next, we investigated the significance of increased integrin
expression with regard to the cell spreading. Cells were pre-
mixed with functional blocking integrin antibodies to preoc-
cupy the integrins on the cell surface and then replated. Pre-
incubation with anti-integrin 2 (clone P1E6) or 3 (clone
P1B5), but not 5 (clone P1D6), antibody inhibited the cell
spreading (Fig. 5A) and phosphorylation of the FA molecules
(Fig. 5B). Interestingly, phosphorylation of the FA molecules
was more effectively reduced by integrin 3 blockage than
integrin 2 blockage, presumably indicating a specificity of
signal transduction through integrin subtypes. However, the
integrin blocking study did not reduce PKC expression or
Ser643 phosphorylation, indicating that PKC acts upstream of
the integrins (Fig. 5B). Meanwhile, the PKC level was not
changed by TGF1 treatment (Fig. 5B), indicating again that
FIG. 2. PKC pathway correlated with the integrin- and TGF1-
mediated cell spreading. (A) Integrin- and TGF1-mediated cell
spreading was abolished by PKC inhibition using GF-109203X (GF)
and rottlerin (Rot). The cells were pretreated with GF-109203X (12.5
M) or rottlerin (10 M) 30 min prior to replating on Fn and TGF1
treatment for 20 h. (B) Phosphorylation of PKC serine 643 was
increased by TGF1 treatment for 20 h and correlated with the inte-
grin- and TGF1-mediated cell spreading. The cells were manipulated
as in panel A. GF-109203X was treated as explained above. After the
incubation for 20 h, cell lysates were prepared as described in Mate-
rials and Methods. Data shown are representative of several indepen-
dent experiments.
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FIG. 3. Integrin- and TGF1-mediated cell spreading on fibronectin involves phosphorylation of focal adhesion molecules. Manipulation of
cells and preparation of cell lysates were done the same as for Fig. 2. Cell lysates were analyzed by Western blotting or indirect immunofluorescent
microscopy using primary antibodies against the indicated molecules. The data shown are representative of several experiments. (A) TGF1
treatment increased phosphorylation of the FA molecules and expression and Ser643 phosphorylation of PKC, in a time-dependent manner. Cells
were treated with 5 ng/ml TGF1 for the indicated hours at the end of the 20-h incubation on fibronectin (i.e., 1 h indicates that TGF1 was directly
added to the replating media after 19 h on Fn and the whole-cell extracts were prepared after one additional hour of incubation). (B) Integrin- and
TGF1-mediated phosphorylation of the FA molecules was significantly reduced by PKC inhibition. Cells were pretreated with the indicated PKC
inhibitors (12.5 M GF-109203X [GF] or 10 M rottlerin [Rot]), 30 min prior to the replating on Fn. (C) Expression of FRNK (dominant-negative FAK
inhibitor), inactive c-Src (Y416F c-Src), or dominant-negative paxillin (Y31/118/157F paxillin) abolished the cell spreading. Cells were cotransfected with
FRNK and GFP, Y416F c-Src and GFP, or Y31/118/157F paxillin and GFP. Two days later, cells were immunostained with rabbit anti-pY397FAK and then
anti-rabbit IgG-conjugated TRITC. (D) FAK-p130Cas and p130Cas-Nck interactions correlated with the TGF1 effects. Cell lysates were subjected to
immunoprecipitation with mouse monoclonal anti-FAK or Nck antibodies, and the immunoprecipitates were used in immunoblots using antibodies
against the indicated molecules. The data shown were representative of three isolated experiments.
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FIG. 4. TGF1-, PKC-, and integrin-mediated cell spreading required new protein synthesis. (A) Inhibition of protein synthesis abolished
phosphorylation of the FA molecules (left) and cell spreading (right) by TGF1 treatment. Cell replating and a concomitant TGF1 treatment
were done, as described above. Twelve hours after the replating, certain cells were treated with 10 g/ml cycloheximide every 4 h during an
additional 8-h incubation with TGF1 treatment at 37°C. Cell images were taken using a phase-contrast microscope, and whole-cell lysates were
prepared and used in Western blots as explained earlier. Data shown were representative of three independent experiments. (B) TGF1-mediated
effects on integrins and ECM expression levels. Cell lysates were immunoblotted for antibodies against indicated integrins or collagen I or 3 chain
of human laminin 5 (LN5-3) (19, 35). Data shown were representative of three isolated experiments. (C) Increases in integrin 2 and 3
expression levels by TGF1 in a time-dependent manner. Cells from the indicated conditions were analyzed for integrin 2 or 3 expression by
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FIG. 5. The TGF1 effects depend on expression and activation of integrins 2 or 3. The cells were pretreated with 10 g/ml anti-integrin
2 (P1E6), 3 (P1B5), or 5 (P1D6) antibodies, 30 min prior to the replating on Fn and a concomitant TGF1 treatment for 20 h. After the
incubation, cell images were taken, and lysates were prepared and used in immunoblots using antibodies against the indicated molecules. Data
shown are representative of two isolated experiments. (A) Functional blocking anti-integrin 2 or 3, but not 5, antibodies abolished the cell
spreading. (B) Functional blocking of the integrins inhibited phosphorylation of the FA molecules. (C) Cells were transiently cotransfected with
a control plasmid (C) or pSF2-integrin 2 or 3 with pCDNA3-GFP. One day after the transfection, cells were replated onto Fn (10 g/ml)-
precoated cover glasses in the absence of TGF1 treatment. After incubation for 20 h at 37°C and 5% CO2, cells were processed for actin staining
with phalloidin-conjugated TRITC. Another set of cells in 60-mm culture dishes were harvested for lysates prior to performing immunoblotting
using the indicated antibodies. BLK mAb, functional blocking monoclonal antibody.
flow cytometry. Histograms are shown for controls with no primary antibody (C) and TGF1-treatment for 0 h (1), 8 h (2), 12 h (3), and 20 h (4).
(D) Blockage of TGF1-induced integrin 2 or 3 expression by PKC inhibition. Histograms included are for no primary antibody control (C),
no TGF1 treatment (1), TGF1 treatment for 20 h (2), and GF-109203X pretreatment 30 min prior to TGF1 treatment for 20 h (3). (E) The
TGF1-mediated effects on integrin and PKC inductions were reduced by Smad7 overexpression. Twenty-four hours after the infection of cells
with adenovirus encoding for -galactosidase (LacZ) or Flag-Smad7, cells were replated on Fn in the absence or presence of TGF1 treatment
for 20 h. Cell lysates were prepared and used in Western blots with antibodies against the indicated molecules. Data shown were representative
of three independent experiments.
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FIG. 6. Integrin- and TGF1-mediated cell spreading requires PKC expression and activation. (A) Infection with adenovirus for PKC WT
(Ad-PKC) increased the expression and Ser643 phosphorylation level of PKC. Cells were infected with various amounts of Ad-PKC. Two days
later, cell lysates were prepared and used in Western blots for the indicated molecules. Data shown were representative of three independent
experiments. (B) Increased activity and expression level of PKC by viral infection enhanced phosphorylation of the FA molecules. Cells were
infected with a control adenoviral vector (Ad-LacZ) or Ad-PKC. Twenty-four hours later, cells were replated on Fn. Certain cells were pretreated
with GF-109203X (GF) or Rottlerin (Rot), as described for Fig. 2. After the 20-h incubation on Fn, cell lysates were prepared and used in Western
blots with antibodies against the indicated molecules. Data shown were representative of three different experiments. (C) Integrin- and TGF1-
mediated cell spreading on Fn was accelerated by Ad-PKC infection. Cells infected with Ad-LacZ or Ad-PKC were replated on Fn with a
concomitant TGF1 treatment for the indicated periods at the end of the 20-h incubation. Images were taken after the incubation on Fn.
Quantitation of spread cells (cells with the longest distance from one end to the other end at least twice longer than the shortest distance) were
counted from five isolated images of each experimental condition, and average values were graphed (mean  standard deviation). A P value less
than 0.05 from paired Student’s t tests was considered significant. (D) Phosphorylation of the FA molecules was abolished by suppression of PKC
protein. Cells were first transfected with siRNA to down-regulate PKC (PKC siRNA) or a control siRNA (Cont siRNA). Twenty-four hours after
the transfection, cells were manipulated to be replated on Fn for the indicated experimental conditions. Cell lysates were then prepared and used
for Western blots. Data shown represent three independent experiments. (E) Cell spreading was abolished by suppression of PKC protein. Cells
were manipulated as explained for panel D, except that a part of the cells cotransfected with pcDNA3-GFP plus control siRNA or PKC siRNA
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the TGF1-mediated effects did not involve PKC (also as
indicated in Fig. 2B and 6F). Therefore, we suggest that the
cell spreading requires increased expression and activation of
integrins 2 and 3, which function downstream of PKC.
However, overexpression of human integrin 2 or 3 did not
lead to cell spreading when TGF1 was not treated (Fig. 5C),
indicating that additional TGF1-mediated signaling activity
in addition to integrin expression is necessary for the cell
spreading.
Regulation of PKC expression and activity affects the cell
spreading. Because PKC Ser643 phosphorylation correlated
with the cell spreading during the inhibitor experiments, we
investigated the significance of PKC in promoting cell spread-
ing through regulation of PKC expression and phosphoryla-
tion. When cells were infected with various amounts of PKC
WT-expressing adenovirus (Ad-PKC), Ser643 phosphoryla-
tion and the expression level of PKC dramatically increased
(Fig. 6A). Thus, we could use the Ad-PKC to enable PKC
overexpression and Ser643 phosphorylation. We next investi-
gated whether PKC overexpression (and thus Ser643 over-
phosphorylation) could cause enhanced activation of the
spreading-related FA molecules. PKC overexpression en-
hanced Ser643 phosphorylation of PKC, expression of inte-
grin 2, and TGF1-mediated activation of the FA molecules,
but GF-109203X or rottlerin treatment abolished the enhance-
ments (Fig. 6B). Moreover, compared to cells infected with the
control adenovirus (Ad-LacZ), spreading of PKC-overex-
pressing cells was minor in the absence of TGF1 and was
much more enhanced by TGF treatment (Fig. 6C). Next, we
tested if PKC down-regulation through its siRNA transfec-
tion affected the spreading. PKC suppression attenuated ac-
tivation of the FA molecules and the integrin 2 expression
level (Fig. 6D). PKC-suppressed cells did not spread, whereas
normal neighbor cells spread (Fig. 6E). These data indicate
that PKC indeed mediates TGF1-induced phosphorylation
of the FA molecules, expression of the integrins, and cell
spreading. Meanwhile, overexpression of PKC using adeno-
virus with its cDNA did not cause additional enhancement of
FA molecules phosphorylation, and dominant-negative PKC
could not abolish the TGF1-mediated spreading (Fig. 6F).
These observations suggest that the cell spreading involves
PKC, but not PKC, signaling.
The more sufficiently the integrin-related signaling is acti-
vated, the better the cell spreading. In this study, PKC over-
expression alone did not cause significant activation of the FA
molecules (Fig. 6B, left, lanes 1 and 4) and led to a minor
spreading (Fig. 6C), although additional TGF1 treatment
caused complete and accelerated spreading (Fig. 6C). There-
fore, we hypothesized that a slight increase in either integrin
signaling (Fig. 7A, B, and C) or TGF1 signaling (Fig. 7D and
E) might facilitate the cell spreading. To test this possibility, we
first examined the effects of cell replating on various ECM-
precoated dishes on activation of the FA molecules and the
cell spreading. Activation of the FA molecules was increased
by TGF1 on the tested ECMs but not significantly on poly-
L-lysine (Fig. 7A). Interestingly, basal (without TGF1 treat-
ment) phosphorylation of the FA molecules was higher on
collagen I than any of the other tested ECMs (Fig. 7A, lane 5).
We thus examined the spreading behavior of cells overexpress-
ing PKC on collagen I. PKC overexpression induced cell
spreading (Fig. 7B) and consistently increased basal phosphor-
ylation of the FA molecules and integrin 2 expression, com-
pared to those in Ad-LacZ-infected cells (Fig. 7C, lanes 1 and
4) even without TGF1 treatment. It appeared that higher
basal integrin signaling activity could cause the cell spreading
even without TGF1 treatment. Furthermore, compared to
the Ad-LacZ-infected cells, quantitatively (i.e., higher spread-
ing rate) and qualitatively (i.e., wider spreading) enhanced cell
spreading by TGF1 treatment was observed on collagen I
(Fig. 7B). Interestingly, being consistent with the quantitatively
and qualitatively enhanced spreading, the TGF1-increased
phosphorylation of the FA molecules and expression level of
integrin 2 were observed in PKC-overexpressing cells (Fig.
7B and C, lanes 2 and 5). In addition, this spreading was
blocked by PKC inhibition (Fig. 7B), as decreased phosphor-
ylation of the FA molecules and suppressed expression of
integrins by PKC inhibition (Fig. 7C). We next investigated if
an increased TGF1 signaling presumably through Smad2 or
Smad3 overexpression would affect the spreading. The TGF1
effects were investigated using cells infected with adenovirus
encoding for either -galactosidase or FLAG-tagged Smad2 or
Smad3 that still require TGF1 treatment for their activation
(30). Interestingly, overexpression of Smad3, but not Smad2,
enhanced the TGF1-mediated activation of the FA mole-
cules, expression and Ser643 phosphorylation of PKC, expres-
sion of integrin 2 (Fig. 7D), and cell spreading (Fig. 7E) in a
PKC activity-dependent manner. Therefore, these observa-
tions suggest the significance of the Smad3-dependent TGF1
signaling in expression and activation of PKC and integrins,
activation of the FA molecules, and the spreading.
The cell spreading-related signaling network also increased
migration and invasion through matrigel. Cell spreading may
enable a cell to respond to extracellular cues during migration
and invasion. To investigate whether cell spreading and
spreading-related biochemical activities correlate with cell mo-
tility and invasiveness, we performed wound-healing and inva-
sion assays. Compared with the untreated cells, wound healing
was significant in the TGF1-treated cells on Fn, in a PKC
activity-dependent manner. This increased wound healing was
not due to alteration in cell proliferation or apoptosis (data not
were replated on Fn-precoated cover glasses. Cells on cover glasses were processed for actin staining using phalloidin-conjugated TRITC. The
other part of the cells was harvested after the 20-h incubation, and the lysates were immunoblotted using the indicated antibodies. Data shown
were representative of three isolated experiments. (F) PKC appeared not to be involved in the TGF1 effects. (Left) No enhancement of
phosphorylation of the FA molecules upon PKC overexpression. Cells were infected with either control virus (Ad-LacZ) or PKC adenovirus
(Ad-PKC). One day after, cells were replated on Fn for the 20-h incubation under the indicated conditions. Lysates were prepared after the
incubation and used in the immunoblots for the indicated molecules. (Right) Cells were infected with dominant-negative PKC adenovirus
(Ad-DN PKC). Twenty-four hours later, cells were replated on Fn for the 20-h incubation in the presence of TGF1 treatment. After the
incubation, the cell image was taken and then lysates were prepared for the immunoblots for the indicated molecules. Data shown were
representative of 3 independent experiments.
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shown) but presumably was due to migration of cells towards
the wounds. When cells overexpress PKC, TGF1-induced
wound healing was further enhanced, but slightly higher than
that of TGF1-treated normal control cells (Fig. 8A). This
increased motility by TGF1 treatment and PKC activity in
cells on Fn indicate that the motility appears to correlate with
the spreading behaviors. In addition, the TGF1-treated cells
showed increased invasion through matrigel dependent on
PKC activity, compared with the untreated cells. Furthermore,
cells overexpressing PKC also showed more enhanced inva-
sion, also depending on PKC activity (Fig. 8B). Therefore, the
signaling network required for the cell spreading was also
involved in the motility and invasion, indicating that the mo-
tility and invasion correlate with the spreading behaviors.
DISCUSSION
In this study, we explored the signaling mechanisms under-
lying the cell spreading process alone, separated from adhe-
sion, using gastric carcinoma SNU16mAd cells. These cells are
normally round but spread polygonally by TGF1 treatment in
the absence or presence of serum. The TGF1-mediated
spreading depends on integrin interaction with ECMs and sig-
nal transduction involving PKC. We found that this spreading
of gastric carcinoma cells involved induction and Ser643 phos-
phorylation of PKC, expression and activation of integrins
(2 and 3), and activation of the FA molecules. Furthermore,
the spreading-related signaling activities were involved in the
wound healing and invasion. Observations from this study sug-
gest that the signaling network involving TGF1, PKC, and
integrins underlies spreading and migration and invasion of an
adherent gastric carcinoma variant cell line, SNU16mAd.
SNU16mAd cells used in this study were obtained from
subsequent cultures to collect adherent cells among mostly
anchorage-independent SNU165 cells (18). A long period
was required for adherence when the cells were replated on
Fn-precoated dishes, and the cell shape appeared round even
when fully adhered to the substrate. When cells replated on Fn
were treated with TGF1 for a long period (e.g., 20 h), the
cells became spread. Therefore, this cell line is a good model
system to study cell spreading events by specific stimuli, sepa-
rate from the adhesion process. This may be an important
distinction, as many normally adherent cell types spread grad-
ually and spontaneously after being replated.
So far, signaling networks consisting of integrins, TGF1,
and PKC (especially PKC) have not been thoroughly investi-
gated, especially for cell spreading and invasiveness, although
a previous report showed that general PKC activity preceded
integrin-mediated cell adhesion on fibronectin (41). In this
study, we demonstrated a complicated signaling network un-
derlying a specific cellular behavior (i.e., cell spreading). Smad-
dependent TGF1 signaling led to increased expression and
Ser643 phosphorylation of PKC, which correlated with induc-
tion and activation of integrins, activation and stable complex
formation of the FA molecules, and cell spreading. Although
the effects of TGF1 and integrins on metastasis have been
previously reported (11, 20, 42), the positive involvement of
PKC in the migration and invasion has not been fully eluci-
dated. The observations from this study suggest that the
spreading correlates with increased motility and invasion, since
TGF1-mediated wound healing and invasion also depended
on PKC expression and activation and integrin-related signal-
ing activation. The TGF1-mediated wound healing on Fn in
PKC-overexpressing cells could be slightly enhanced, com-
pared to that of TGF1-treated normal control cells, probably
because this cell line is much less motile in the absence of
serum. This observation was consistent with a slight (but sta-
tistically significant) increase in quantitative spreading rate
that was accompanied by a qualitatively wider spread (Fig. 6C).
In addition to the PKC inhibitor studies, overexpression by
PKC adenovirus and down-regulation by PKC siRNA
showed the significance of PKC in the cell spreading, wound
healing, and invasion. Among other PKC isoforms, PKC/II,
PKC	/
, and -ε appeared not to be involved in the system
because their phosphorylation status did not correlate well
with the cell spreading patterns under the experimental con-
ditions, and PKC was not expressed in our cells. In addition,
PKC and PKC overexpression did not result in spreading on
fibronectin. More conclusively, cells infected with adenovirus
with dominant-negative PKC could still spread on fibronectin
upon TGF1 treatment. Therefore, it is likely that the TGF1-
mediated spreading involves PKC at least, but not PKC and
-, and that PKC is a mediator for TGF1 to integrin signal-
ing pathways and acts upstream of integrins and the FA mol-
ecules (Fig. 9).
On the other hand, the signaling network of TGF1, PKC,
integrins, and integrin-related signaling molecules appeared to
be complicated rather than in order. First, overexpression of
PKC in the absence of TGF1 treatment did not result in a
complete spreading, although TGF1 treatment facilitated the
spreading of PKC-overexpressing cells, compared to control
cells. Second, overexpression of integrins 2 or 3 did not
cause spreading in the absence of TGF1. These observations
indicate that just a linear connection from the Smad-depen-
dent TGF1 pathway to integrin induction and activation via
PKC induction and phosphorylation is not sufficient for the
spreading and that probably different TGF1-mediated bio-
chemical actions function to activate and/or assemble down-
stream effectors (complexes), such as the FA molecules (Fig.
9). Recently there has been diverse evidence that TGF1 ac-
tivates diverse intracellular signaling molecules that are also
regulated by integrin-mediated cell adhesion (7, 28).
In this study, incubation of the cells with TGF1 for 20 h in
the absence of serum increased Ser643 phosphorylation as well
as expression of PKC. However, it is currently a controversial
assumption that Ser643 phosphorylation affects kinase activity
of PKC. One previous study reported that a Ser643 to alanine
mutation had no effect on the kinase activity of PKC (39),
whereas another showed that Ser643 of PKC is an important
autophosphorylation site for its enzymatic activity (26). Fur-
thermore, we observed that TGF1 treatment for only 6 or 8
h caused Ser643 phosphorylation of PKC but not induction of
PKC and integrins, phosphorylation of the FA molecules, and
cell spreading (data not shown). We also found that 15-h
TGF1-free incubation even after 5-h TGF1 treatment
caused the TGF1 effects (data not shown), indicating that the
TGF1 treatment alone for such a short period (e.g., for 6 or
8 h) was not enough to cause the TGF effects. Therefore, it
is likely that the Ser643 phosphorylation of PKC is not critical
for the cell spreading, although TGF1 treatment for 20 h
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FIG. 7. Cells under more efficient integrin-related signaling activities lead to enhanced cell spreading. (A) Phosphorylation of the FA molecules in
cells replated on poly-L-lysine or diverse ECM proteins. Cells were replated on culture dishes precoated with various ECMs (10 g/ml) (Coll, collagen
I; Ln, laminin I; Vn, vitronectin), in the absence or presence of TGF1 treatment for 20 h. Cell lysates were then prepared and used for Western blots
with antibodies against the indicated molecules. Data shown represent three independent experiments. (B) Spreading of PKC WT-overexpressing cells
on collagen I even without TGF1 treatment. Twenty-four hours after infection with Ad-LacZ or Ad-PKC, cells were manipulated to be replated on
collagen I-precoated dishes. Certain cells were pretreated with GF-109203X (GF), as described above. Twenty hours after the replating, images were
taken. The rate of spread cells in percent graphed was determined as explained for Fig. 6C. A P value of 0.05 was considered significant. (C) Cells
infected with Ad-PKC enhanced basal and TGF1-mediated expression of integrin 2 and phosphorylation of the FA molecules on collagen I. Cell
manipulation and cell lysate preparation were performed, as explained above. Data shown were representative of three independent experiments. (D,
E) Smad3 overexpression enhanced TGF1-mediated phosphorylation of the FA molecules (D) and cell spreading (E). Cells were infected with
adenovirus encoding for either control (Ad-LacZ), Flag-Smad2 (Ad-Smad2), or Flag-Smad3 (Ad-Smad3). Twenty-four hours later, infected cells were
replated on Fn. In certain cases, GF-109203X or Rottlerin (Rot) pretreatment was done as explained above. After 20 h of incubation at 37°C, cell lysates
were prepared for Western blots, or cell images were taken. Quantitative determinations of the spread cells were done as explained for Fig. 6C. A P value
of 0.05 was considered significant. Data shown were representative of three isolated experiments.
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FIG. 7—Continued.
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resulted in the phosphorylation correlated with the spreading.
Although the significance of the Ser643 phosphorylation for
PKC activity is controversial, pharmacological inhibition of
PKC activity abolished the spreading in this study. Therefore,
it appears that the cell spreading importantly involves induc-
tion and activation of PKC and integrins and activation of
integrin-related signaling.
There have been evidences for effects of TGF1 on integrins
and/or ECMs, and vice versa (36). Although the increased
integrins 2 or 3 bind collagen I or laminin 5, respectively
(33), neither collagen I (2 and 1 chains) nor laminin 5 (3
chain) expression levels of the SNU16mAd cells were changed
by TGF1 treatment upon immunoblotting with commercial
antibodies against them (Fig. 4B). Although the TGF1 effect
was shown in all ECMs we tested, we performed most exper-
iments on fibronectin, just because the TGF1-mediated effect
was more obvious with no basal signaling activity on fibronec-
tin, compared to on collagen I or laminin 1, and because these
integrins 2 or 3 also bind to fibronectin (32, 40). We cannot
rule out the possibility that collagen I and/or laminin I might
support the integrins 2 or 3 enhanced by TGF1, since the
cells still expressed them, although their expressions were not
enhanced by the TGF1 treatment. We did not see TGF1-
mediated spreading on fibronectin when integrin 5 (a typical
Fn receptor) was ectopically overexpressed (data not shown),
being consistent with no change in integrin 5 by TGF1.
Furthermore, the cell spreading was abolished by functional
blocking of integrins 2 or 3, but not 5, using their inhibitory
monoclonal antibodies. Therefore, we can conclude that the
TGF1-, PKC-, and integrin-mediated spreading involves in-
creases in specific integrin 2 or 3 expression, presumably,
but not increases in ECM production. On the other hand, it
may be likely that integrins 2 or 3 have specific and exclusive
linkage(s) to the FA molecules, although both were shown to
be involved in this spreading system. We observed that integrin
3 expression increased suddenly at a specific time point pre-
sumably after signal accumulations by TGF1 treatment sur-
passed a threshold (Fig. 4C). However, integrin 2 expression
is increased gradually in a time-dependent manner after
TGF1 treatment. This narrower window of TGF1-mediated
integrin 3 increase rendered the changes in the integrin 3
expression level much more difficult to detect. Furthermore,
phosphorylation of the pY118Paxillin was abrogated by inte-
grin 3 blocking, using anti-integrin 3 monoclonal antibody,
but not significantly by integrin 2 blocking, whereas
pY397FAK was abrogated by both inhibitory antibodies. These
observations may suggest a specific role(s) of each integrin
subtype for the TGF1-mediated FA molecule activation.
We showed in Fig. 7A that basal (without TGF1 treatment)
activation of the FA molecules was more prominent on colla-
gen I and was much more enhanced by TGF1 treatment,
compared to on Fn. This higher basal activation of the FA
molecules correlated with cell spreading on collagen I with
PKC overexpression alone even in the absence of TGF1
treatment, and TGF1-mediated activity might correlate with
a wider spreading (Fig. 7B). Therefore, depending on the
ECM, spreading of SNU16mAd cells may require different
signaling activities for complete and sufficient spreading. On
collagen I, integrin and PKC signal pathways were enough for
the spreading, and additional TGF1 signaling activity corre-
lated with (qualitatively) wider spreading. Meanwhile, the
spreading on Fn appears to additionally require TGF1 sig-
naling probably to support the PKC and integrin signaling,
and the combined signaling output through complicated signal
connections may lead to complete cell spreading (Fig. 9).
All together, in this study, the positive roles of PKC in the
TGF1 and integrin effects on cellular functions were clearly
FIG. 9. Schematic working model of the TGF1-, PKC-, and in-
tegrin-mediated cellular functions in gastric carcinoma cells. TGF1
treatments of cells on ECMs lead to increased expression and phos-
phorylation of PKC, cell surface levels of integrins 2 or 3, and
activation of the focal adhesion molecules. This signaling network
results in spreading, migration, and invasion of the SNU16mAd gastric
carcinoma cell variant. In addition to a linear connection, presumably
additional bypassing connections may contribute to the TGF1 effects.
FIG. 8. Wound healing and invasion also depend on TGF1, PKC, and integrins. (A) TGF1- and PKC activity-mediated wound healing on
Fn. Prior to making wounds, normal or Ad-PKC-infected cells were replated onto Fn-precoated six-well culture plates. Twelve hours later,
wounds (marked as dotted lines) were created by scraping through the monolayer. Cells were then incubated in the absence or presence of TGF1
treatment without or with PKC inhibition (GF-109203X [GF] or rottlerin [Rot]) for 36 h at 37°C, prior to taking images. Note that TGF1-
mediated healing in PKC-overexpressing cells is slightly enhanced, compared to that in normal control cells (i.e., compare healing around the
vertical arrowheads). (B) TGF1- and PKC activity-mediated invasion of the cells through matrigel. Normal or Ad-PKC-infected cells in RPMI
1640 containing 1% BSA were replated onto matrigel, prepared as explained in Materials and Methods, and concomitantly treated with or without
5 ng/ml TGF1. Certain cells were pretreated with 12.5 M GF-109203X, 30 min prior to the TGF1 treatment. Then the upper chambers were
placed into 24-well culture dishes containing 0.6 ml of RPMI 1640 with 10% fetal bovine serum (FBS) or with 1% BSA. After incubation at 37°C
for 72 h, invasive cells were fixed and stained with crystal violet, and then images were taken, as explained in Materials and Methods. The images
shown are representative of three isolated experiments. Stained cells in three independent images for each condition were counted for the graphic
presentation (mean  standard deviation).
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suggested by the observations that PKC is required to medi-
ate TGF1 treatment for integrin expression and activation,
leading to spreading, migration, and invasion of human gastric
carcinoma SNU16mAd cells.
ACKNOWLEDGMENTS
We deeply thank Jang-Soo Chun (Gwangju Institute of Science and
Technology, Gwangju, Korea) for adenovirus encoding for PKC or
PKC and Rudy L. Juliano (University of North Carolina at Chapel
Hill, Chapel Hill, NC) for expression vectors such as pBS-FRNK and
etc, respectively.
This work was supported by a Korea Research Foundation Grant
(KRF-2004-015-C00445) to J. W. Lee.
REFERENCES
1. Akhurst, R. J., and R. Derynck. 2001. TGF- signaling in cancer—a double-
edged sword. Trends Cell Biol. 11:S44–S51.
2. Alahari, S. K., P. J. Reddig, and R. L. Juliano. 2002. Biological aspects of
signal transduction by cell adhesion receptors. Int. Rev. Cytol. 220:145–184.
3. Arthur, W. T., and K. Burridge. 2001. RhoA inactivation by p190RhoGAP
regulates cell spreading and migration by promoting membrane protrusion
and polarity. Mol. Biol. Cell 12:2711–2720.
4. Bhowmick, N. A., R. Zent, M. Ghiassi, M. McDonnell, and H. L. Moses.
2001. Integrin 1 signaling is necessary for transforming growth factor-
activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276:46707–
46713.
5. Bruce-Staskal, P. J., and A. H. Bouton. 2001. PKC-dependent activation of
FAK and Src induces tyrosine phosphorylation of Cas and formation of
Cas-Crk complexes. Exp. Cell Res. 264:296–306.
6. Buday, L., L. Wunderlich, and P. Tamas. 2002. The Nck family of adapter
proteins: regulators of actin cytoskeleton. Cell. Signal. 14:723–731.
7. Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-indepen-
dent pathways in TGF- family signalling. Nature 425:577–584.
8. Eliceiri, B. P. 2001. Integrin and growth factor receptor crosstalk. Circ. Res.
89:1104–1110.
9. Engel, M. E., M. A. McDonnell, B. K. Law, and H. L. Moses. 1999. Inter-
dependent SMAD and JNK signaling in transforming growth factor--me-
diated transcription. J. Biol. Chem. 274:37413–37420.
10. Gschwendt, M., H. J. Muller, K. Kielbassa, R. Zang, W. Kittstein, G. Rincke,
and F. Marks. 1994. Rottlerin, a novel protein kinase inhibitor. Biochem.
Biophys. Res. Commun. 199:93–98.
11. Guo, W., and F. G. Giancotti. 2004. Integrin signalling during tumour pro-
gression. Nat. Rev. Mol. Cell Biol. 5:816–826.
12. Hartsough, M. T., and K. M. Mulder. 1995. Transforming growth factor 
activation of p44MAPK in proliferating cultures of epithelial cells. J. Biol.
Chem. 270:7117–7124.
13. Hayashida, T., and H. W. Schnaper. 2004. High ambient glucose enhances
sensitivity to TGF-1 via extracellular signal-regulated kinase and protein
kinase C activities in human mesangial cells. J. Am. Soc. Nephrol. 15:2032–
2041.
14. Hocevar, B. A., T. L. Brown, and P. H. Howe. 1999. TGF- induces fibronec-
tin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-indepen-
dent pathway. EMBO J. 18:1345–1356.
15. Hynes, R. O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell
110:673–687.
16. Ignotz, R. A., and J. Massague. 1987. Cell adhesion protein receptors as
targets for transforming growth factor- action. Cell 51:189–197.
17. Juliano, R. L. 2002. Signal transduction by cell adhesion receptors and the
cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobu-
lin-superfamily members. Annu. Rev. Pharmacol. Toxicol. 42:283–323.
18. Kim, H. P., M. S. Lee, J. Yu, J. A. Park, H. S. Jong, T. Y. Kim, J. W. Lee, and
Y. J. Bang. 2004. TGF-1 (transforming growth factor-1)-mediated adhe-
sion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellu-
lar-signal-regulated kinases) cascade activity dependent on c-Src activity.
Biochem. J. 379:141–150.
18a.Kim, H. P., T. Y. Kim, M. S Lee, H. S Jong, T. Y. Kim, J. W. Lee, and Y. J.
Bang. 2005. TGF-1-mediated activations of c-Src and Rac1 modulate levels
of cyclins and p27Kip1 CDK inhibitor in hepatoma cells replated on fibronec-
tin. Biochim. Biophys. Acta 1743:151–161.
19. Kim, M. G., G. Lee, S.-K. Lee, M. Lolkema, J. Yim, S. H. Hong, and R. H.
Schwartz. 2000. Epithelial cell-specific laminin 5 is required for survival of
early thymocytes. J. Immunol. 165:192–201.
20. Koivunen, J., V. Aaltonen, S. Koskela, P. Lehenkari, M. Laato, and J.
Peltonen. 2004. Protein kinase C / inhibitor Gö6976 promotes formation
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